(nyse: american aim) (aim or the company), an immuno-pharma company focused on the research and development of therapeutics to. More Company Releases for AIM ImmunoTech Inc. ocala, fla., (globe newswire) - aim immunotech inc. AIM ImmunoTech (AIM) Stock Forecast, Price & News 0.70 0.00 (-0.04) (As of 09:30 AM ET) Today's Range 0.70 0.70 50-Day Range 0.70 0.93 52-Week Range 0.55 2.20 Volume 300 shs Average Volume 181,579 shs Market Capitalization 33. Potential Drug for Fatigue to Get New Review The Wall Street Journal Interactive EditionĭRDGold's Shares Rise BioFuel Energy Soars The Wall Street Journal Interactive Edition Panel Rejects Drug for Chronic Fatigue Syndrome The Wall Street Journal Interactive EditionįDA Questions Hemispherx's Fatigue Drug The Wall Street Journal Interactive Edition
![aim immunotech stock aim immunotech stock](https://wallmine.com/og-image/nysemkt:aim.png)
How much money does AIM ImmunoTech make AIM ImmunoTech (NYSE:AIM) has a market.
![aim immunotech stock aim immunotech stock](https://markets.immunofrontiers.com/wp-content/uploads/2022/07/imgonline-com-ua-CompressToSize-Ocq1veUrBl.jpg)
Tiny biotech says it may have an answer for Ebola MarketWatch One share of AIM stock can currently be purchased for approximately 0.73. It is engaged in the clinical development of drug therapies based on natural immune system. Use the PitchBook Platform to explore the full. AIM ImmunoTech Inc is a US-based specialty pharmaceutical company. Over the past year the S&P 500 has risen 14.67. Hemispherx Biopharma started at buy with $8 stock price target at Maxim Group MarketWatch Information on stock, financials, earnings, subsidiaries, investors, and executives for AIM ImmunoTech. To buy US shares you must first complete and return a US government W-. AIM is lower by -0.11 from the previous closing price of 2.18 on volume of 1,534,891 shares.
![aim immunotech stock aim immunotech stock](https://alphastocknews.com/wp-content/uploads/2019/11/AIM-ImmunoTech-AIM-Stock-News-768x508.jpg)
UnitedHealth stock leads health-care stock rally after Biden’s Super Tuesday victory MarketWatchĪIM ImmunoTech upgraded to buy from hold, sets $2.00 stock price target at Maxim Group MarketWatch Inovio shares rally after biotech says human trials of coronavirus vaccine will start in April MarketWatch (ASE:AIM)ĪIM ImmunoTech stock price target raised to $6.50 from $2.75 at Alliance Global Partners MarketWatch